ClinicalTrials.govpublic full text
Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy
sarcoma, kaposi, hiv infections, etoposide, acquired immunodeficiency syndrome, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 912298
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.